DAFNA Capital Management LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
DC DAFNA Capital Management LLC | Institutional Filer | ▲ 2.11% | $439.6M | 83 |
Current Portfolio Holdings
Showing all 83 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines, Inc. | Healthcare | 581K | $56.5M | 12.85% |
| 2 | XBI | SPDR S&P BIOTECH ETF | — | 319K | $40.7M | 9.25% |
| 3 | STXS | Stereotaxis, Inc. | Healthcare | 13.7M | $25.2M | 5.73% |
| 4 | DAWN | Day One Biopharmaceuticals, Inc. | Healthcare | 978K | $21.0M | 4.77% |
| 5 | ATRC | AtriCure, Inc. | Healthcare | 597K | $17.0M | 3.88% |
| 6 | IDYA | IDEAYA Biosciences, Inc. | Healthcare | 477K | $15.9M | 3.61% |
| 7 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 251K | $14.6M | 3.32% |
| 8 | CYTK | Cytokinetics, Incorporated | Healthcare | 217K | $14.3M | 3.26% |
| 9 | CMPS | COMPASS Pathways plc | Healthcare | 2.4M | $13.4M | 3.04% |
| 10 | NKTR | Nektar Therapeutics | Healthcare | 165K | $11.9M | 2.70% |
| 11 | IBB | ISHARES NASDAQ BIOTECH INDX | — | 62K | $10.5M | 2.39% |
| 12 | RCUS | Arcus Biosciences, Inc. | Healthcare | 444K | $9.6M | 2.18% |
| 13 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 71K | $9.3M | 2.12% |
| 14 | LRMR | Larimar Therapeutics, Inc. | Healthcare | 2.0M | $9.1M | 2.08% |
| 15 | BCAX | Bicara Therapeutics Inc. Common Stock | Healthcare | 422K | $8.4M | 1.91% |
Showing 1 to 15 of 83 holdings